TORONTO and HAIFA, Israel, Dec. 06, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (NRX:CA), (OTCQB: NRXBF), (Germany: J90) ("NurExone" or the "Company"), a ...

NurExone Biologic Inc. has reported promising preclinical results for its drug ExoPTEN, which shows potential in repairing optic nerve damage and restoring vision, particularly for conditions like ...

The human body is complex, and many things can go wrong while a baby is developing. Sometimes, genetic mutations occur, or things don’t form quite right. One condition that can result from ...

An optic nerve glioma is a type of noncancerous, slow-growing tumor that develops in the glial cells of the optic nerve. They are most common in children. Doctors may refer to this type of tumor as ...

Current methods for repairing injured nerves can be hit-and-miss and are restricted to repair over short distances. For the first time, researchers have combined two kinds of silk to create a ...

Traumatic injury to the brain, spinal cord and optic nerve in the central nervous system (CNS) are the leading cause of disability and the second leading cause of death worldwide. CNS injuries often ...

New research links two widely used diabetes drugs, semaglutide or tirzepatide, to a rare but potentially vision-threatening eye condition, raising questions about drug-specific risks and the need for ...

What Is Optic Nerve Drusen? Optic nerve drusen is a rare eye condition that affects between 3 and 24 people out of every 1,000 in the population. It’s difficult to estimate exactly how common this ...

The use of GLP-1 receptor agonists, and particularly liraglutide, was associated with an increased risk of developing nonarteritic anterior ischemic optic neuropathy (NAION) during the first year of ...

Traumatic injury to the brain, spinal cord and optic nerve in the central nervous system (CNS) are the leading cause of disability and the second leading cause of death worldwide. CNS injuries often ...